All Brands Owned by TTAM Research Institute

What does TTAM Research Institute own?

TTAM owns substantially all of the former 23andMe operating business, including the Personal Genome Service consumer DNA testing line, the 23andMe research services business, and the Lemonaid Health telehealth unit. It acquired these assets from 23andMe Holding Co. in July 2025.

Is TTAM Research Institute publicly traded?

No. TTAM is a nonprofit public benefit corporation and has no stock. It cannot be publicly traded, and no equity interests exist for public investors.

Who founded TTAM Research Institute?

Anne Wojcicki, the co-founder and former chief executive of 23andMe, founded and leads TTAM Research Institute. The name derives from the initials of her full name.

Where is TTAM Research Institute headquartered?

The organization is based in California, operating out of the San Francisco Bay Area, where 23andMe was historically headquartered.

How many brands does TTAM own?

Its principal consumer brand is 23andMe, plus the Lemonaid Health telehealth service and the 23andMe research business. The portfolio is small and concentrated in consumer health.

Who owns TTAM Research Institute?

Nobody owns it in the conventional sense. As a nonprofit public benefit corporation it has no shareholders and is controlled by its board of directors and mission charter. Anne Wojcicki founded the organization and leads it.

What is TTAM's relationship to Regeneron?

Regeneron Pharmaceuticals won the first bankruptcy auction for 23andMe's assets at 256 million dollars but lost the reopened auction when the court allowed TTAM to bid. TTAM ultimately won with a 305 million dollar offer, so Regeneron holds no ownership interest.